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Abstract 
The extracellular matrix (ECM) is a network of secreted proteins that, beyond providing support for 
tissues and organs, is involved in the regulation of a variety of cell functions, including cell 
proliferation, polarity, migration and oncogenic transformation. ECM homeostasis is maintained 
through a tightly controlled balance between synthesis, deposition and degradation. While the role 
of metalloproteases (MMPs) in ECM degradation is widely recognised, the contribution of ECM 
internalisation and intracellular degradation to ECM maintenance has been mostly overlooked. In 
this review, I will summarise what is known about the molecular mechanisms mediating ECM 
endocytosis and how this process impacts on diseases, such as fibrosis and cancer.  
Introduction 
The extracellular matrix (ECM) is a complex 3 dimensional (3D) network of secreted proteins. The 
matrisome project identified ~300 proteins as core matrisome components [1]. These include 
collagens, proteoglycans (including aggrecan, versican and perlecan) and glycoproteins (such as 
laminins, fibronectin and nidogen). The ECM comes in 2 flavours: the interstitial connective tissue, 
which offers structural scaffolding for tissues, and the basement membrane (BM), which mediates 
the separation between the epithelium and the stroma (figure 1).  
The ECM is constantly remodelled, as a result of a fine balance between synthesis, deposition and 
degradation. The functions of the ECM go beyond providing tissue support. Indeed, the ECM is 
implicated in the control of tissue homeostasis and epithelial morphogenesis, while deregulation of 
ECM remodelling has been linked to several pathological conditions [2]. On one hand, excessive ECM 
degradation leads to tissue destruction in cardiomyopathies and osteoarthritis, indicating the need 
for an intact ECM network to support tissue architecture and homeostasis. On the other hand, ECM 
accumulation is associated with fibrosis and cancer [2]. Cells interact with the ECM through plasma 
membrane receptors, including integrins, dystroglycan (DG), discoid domain receptors (DDRs) and 
mannose receptors (MRs). These are involved in a variety of cell functions, such as proliferation, 
migration and polarity [3].  
Two main ECM degradation pathways have been described: extracellular or pericellular degradation, 
mediated by matrix metalloproteases (MMPs), and lysosomal degradation after receptor-mediated 
internalisation. These are not independent processes, and are more likely to occur in a coordinated 
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fashion, as detailed below. This short review focuses on the molecular mechanisms responsible for 
ECM internalisation and how this process impinges on pathological conditions, such as fibrosis and 
cancer. 
Mechanisms controlling ECM internalisation 
Collagens are the most abundant components of the ECM, accounting for up to 30% of the total 
proteins in human, [3]. Collagen internalisation and degradation is an important step for connective 
tissue homeostasis and is required for physiological collagen turnover. So far, two mechanisms have 
been identified to control collagen internalisation: integrin-mediated phagocytic uptake and 
Endo180-dependent internalisation.  
Ƚ2Ⱦ1 integrin mediates collagen phagocytosis 
Integrins are heterodimers composed of an ɲĂŶĚĂɴƐƵďƵŶŝƚĂŶĚƉƌŽǀŝĚĞĂůŝŶŬďĞƚǁĞĞŶƚŚĞD
and the intracellular cytoskeleton [4]. The DĐƵůůŽĐŚ ŐƌŽƵƉ ŚĂƐ ŝĚĞŶƚŝĨŝĞĚ ɲ ?ɴ ? ŝŶƚĞŐƌŝŶ ĂƐ ƚŚĞ
receptor that mediates collagen I binding in fibroblasts and delineated the molecular pathway 
responsible for collagen phagocytosis in this system (figure 2A). ŝŶĚŝŶŐŽĨĐŽůůĂŐĞŶ/ƚŽɲ ?ɴ ?ƚƌŝŐŐĞƌƐ
the activation of stretch-activated calcium channels [5], leading to an increase in intracellular 
calcium concentration [Ca
++
]i. This mediates the accumulation of the actin-binding protein gelsolin 
and the non-muscular myosin II A (NMMIIA) at the adhesion sites [5]. Gelsolin-dependent nucleation 
of actin filaments is required for phagosome formation and the internalisation of collagen to early 
endosomes [6]. Collagen is then delivered to lysosomes, where it is degraded [7]. Furthermore, at 
least two positive feedback loops reinforce and sustain collagen uptake and degradation. On one 
hand, [Ca
++
]i and the guanine nucleotide exchange factor Vav2 [8] stimulates the small GTPase Rac1 
activation, which promotes integrin clustering [9], while, on the other hand, the phosphorylation of 
NMMIIA by myosin light chain kinase (MLCK) mediates the activation of the small GTPase Rap1, 
which further sustains collagen binding [10]. 
Recent pieces of evidence suggest that collagen phagocytosis is strongly dependent on collagen 
morphology [5], raising the intriguing hypothesis that the complex 3D organisation of the ECM might 
control its ability to be internalised.  
Endo180 mediates clathrin-dependent collagen internalisation 
Endo180 (also known as uPARAP) is a member of the mannose receptor (MR) family. It is 
constitutively internalised to early endosomes (EEs) via clathrin-dependent endocytosis and recycles 
to the plasma membrane. It has been shown to bind to several collagens, including type I, IV and V, 
and is required for collagen internalisation and lysosomal delivery [11-13]. Interestingly, the uptake 
ŽĨ ƐŽůƵďůĞ ĐŽůůĂŐĞŶ ƌĞƋƵŝƌĞƐ ŶĚŽ ? ? ? ďƵƚ ŶŽƚ ɴ ? ŝŶƚĞŐƌŝŶ  ?figure 2B), suggesting that Endo180 
mediates a different mechanism from the phagocytic uptake of fibrillar collagen [14].  In line with 
this, the internalisation of exogenous collagen injected into mouse dermis by fibroblasts does not 
require Endo180 [15]. A similar Endo180-dependent and integrin-independent pathway has been 
described in hepatic stellate cells (HSC), which have a key role on controlling ECM homeostasis in the 
liver [16]. A genome wide RNA interference screen identified Flotillins as important regulators of 
collagen uptake in monocytes and fibroblasts, through the control of Endo- ? ? ? ? ďƵƚ ŶŽƚ ɲ ?ɴ ? ?
protein stability [17]. /ƚ ŝƐ ŶŽƚ ĐůĞĂƌ ǁŚĂƚ ĚŝĐƚĂƚĞƐ ǁŚĞƚŚĞƌ ĐŽůůĂŐĞŶ ŝƐ ŝŶƚĞƌŶĂůŝƐĞĚ ŝŶ ĂŶ ɲ ?ɴ ?- or 
Endo180-dependent manner. Several factors, such as cells from different origins and matrix 
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organisation, may be involved and further studies are needed to clarify this point. Analysis of 
collagen internalisation by several cell lines highlighted a much higher endocytic rate in 
mesenchymal cells compared to normal epithelial cells [14], supporting the role of collagen 
internalisation in connective tissue homeostasis. 
Ⱦ ?-1-dependent fibronectin internalisation 
Fibronectin (FN) is a key component of interstitial ECM and can interact with plasma membrane 
receptors, including integrins and proteoglycans, as well as with other ECM components, such as 
collagen and fibrin [18]. FN is secreted by cells as a soluble covalent dimer and polymerised 
extracellularly to form long fibres [19]. In ŵĂŶǇ ĐĞůů ƚǇƉĞƐ ? ɲ ?ɴ ? ŝŶƚĞŐƌŝŶ ŝƐ ƌĞƐƉŽŶƐŝďůĞfor FN 
ƉŽůǇŵĞƌŝƐĂƚŝŽŶ ? ƚŚƌŽƵŐŚ Ă ƉƌŽĐĞƐƐ ƚŚĂƚ ŝŶǀŽůǀĞƐ ƚŚĞƚƌĂŶƐůŽĐĂƚŝŽŶ ŽĨ ɲ ?ɴ ? ĨƌŽŵ ĨŽĐĂů ĂĚŚĞƐŝŽŶ ƚŽ
more elongated adhesive structures called fibrillar adhesions [20]. Constant FN polymerisation is 
required for collagen I deposition and ECM maintenance. Similarly to collagens, FN turnover is 
mediated by endocytosis and lysosomal degradation. However, this internalisation pathway is 
dependent on caveolin-1 and not on clathrin, suggesting that different ECM components are 
endocytosed via different routes [21] ?/ŶƉĂƌƚŝĐƵůĂƌ ?ɲ ?ɴ ?ŝŶƚĞŐƌŝŶ ?ďƵƚŶŽƚɲǀɴ ? ? is required for the 
internalisation of both soluble and matrix FN by myofibroblasts [22]. In migrating fibroblasts, FN 
ďŝŶĚŝŶŐƚŽɲ ?ɴ ?drives integrin ubiquitination, which promotes the ESCRT-dependent delivery of FN-
ďŽƵŶĚ ɲ ?ɴ ? ƚŽ ŝŶƚƌĂůƵŵŝŶĂů ǀĞƐŝĐůĞƐ  ?/>ss) of multivesicular bodies (MVBs), eventually leading to 
lysosomal degradation [23]. Recent evidence indicates that internalised ECM can also be re-
secreted. In epicardial cells, blood vessel epicardial substance (Bves) and N-myc downstream 
regulated gene 4 (NDRG4) are required for the secretion of internalised FN, by controlling the fusion 
of recycling endosomes with the plasma membrane (PM) [24]. In cancer cells, endocytosed FN is 
redeposited at the basolateral surface through a cortactin-dependent pathway regulating the 
secretion from late endosomes/lysosomes [25]. Finally, the fusion of MVBs with the PM results in 
the release of FN-containing extracellular vesicles known as exosomes (figure 2C); similarly, cortactin 
has recently been shown to control collagen I-containing exosome release [26]. It is not clear which 
mechanisms control FN delivery to different endosomal compartments, resulting in either 
degradation or secretion. 
Ƚ ?Ⱦ ? 
Laminins (LN) are major components of basement membranes (BM), whose remodelling occurs 
through proteolytic degradation, suggesting that LN internalisation could be a potential mechanism 
controlling BM turnover. 
ĂƌůǇ ƐƚƵĚŝĞƐ ŝŶ ŚƵŵĂŶ ďƌĞĂƐƚ ĐĂŶĐĞƌ ĐĞůůƐ ƐŚŽǁĞĚ ƚŚĂƚ ɲ ?ɴ ? ŝŶƚĞŐƌŝŶ ? ďƵƚ ŶŽƚ ɲ ? ŝŶƚĞŐƌŝŶ ?
accumulates at the plasma membrane in regions where ECM degradation occurs. Moreover, 
phagocyƚŽƐĞĚ D ŝƐ ƚƌĂĨĨŝĐŬĞĚ ƚŽŐĞƚŚĞƌ ǁŝƚŚ ɲ ?ɴ ? ƚŽ ĂĐŝĚŝĐ ǀĞƐŝĐƵůĂƌ ĐŽŵƉĂƌƚŵĞŶƚƐ ? ƐƵĐŚ ĂƐ
lysosomes, ĂŶĚ ĂĐƚŝǀĂƚŝŽŶ ŽĨ ɲ ?ɴ ? by binding to LN drives phagocytosis of matrigel and gelatin. 
/ŶƚĞƌĞƐƚŝŶŐůǇ ?ǁŚŝůĞɲ ?ɴ ?ŝƐƌĞƋƵŝƌĞĚĨŽƌECM internalisation, this integrin is not involved in pinocytic 
uptake of a soluble dye ĨƌŽŵƚŚĞŵĞĚŝĂ ?ŝŶĚŝĐĂƚŝŶŐƚŚĂƚɲ ?ɴ ?ƐƉĞĐŝĨŝĐĂůůǇĐŽŶƚƌŽůƐDƉŚĂŐŽĐǇƚŽƐŝƐ 
(figure 2D) [27]. Despite this, it is possible that receptor-independent macropinocytosis might 
contribute to LN internalisation. Indeed, such a mechanism has been described for hyaluronan 
uptake in melanoma cells [28]. 
ECM endocytosis in matrix turnover and cancer  E.Rainero 
4 
 
The trafficking of LN-111 has been recently shown to be receptor-mediated and dynamin-
dependent, leading to lysosomal delivery of LN in normal mammary epithelial cells. Interestingly, LN-
111 internalisation does not require integrins, but the LN receptor dystroglycan (DG) (figure 2D) 
[29]. This pathway is compromised in aggressive cancer, where DG is not functional and LN 
endocytosis is impaired. This suggests that the DG-dependent endocytic trafficking of LN might be 
required for cells-BM communication in normal epithelial cells, while integrin-dependent LN uptake 
might be associated with cancer progression. 
Cross-talk between extracellular proteolysis and matrix internalisation 
The proteolytic cleavage of ECM fibres by MMPs has been suggested to be a pre-requisite for 
receptor-dependent ECM endocytosis. Indeed, a collagen breakdown pathway has been identified 
in fibroblasts, whereby collagen cleavage by collagenases precede Endo180-dependent uptake [30]. 
While both intact and cleaved collagen can be internalised, cleaved collagen shows an increased 
binding to Endo180 and is endocytosed more efficiently. The observation that, even though at a 
slower rate, intact collagen can be internalised is supported by the fact that, in vivo, collagen 
endocytosis is only partially dependent on MMP activity [15], indicating that proteolytic degradation 
facilitates but is not absolutely required for ECM uptake. Similarly, internalisation of matrix FN has 
ďĞĞŶƌĞƉŽƌƚĞĚƚŽďĞƐůŽǁĞƌƚŚĂŶƐŽůƵďůĞ&EĂŶĚ ?ŝŶƚĞƌĞƐƚŝŶŐůǇ ?ǁŚŝůĞɴ ?integrin-null cells are able to 
uptake soluble FN, the endocytosis of matrix FN is completely impaired [22]. This can be explained 
considering ƚŚĂƚĐůƵƐƚĞƌŝŶŐŽĨɴ ?ŝŶƚĞŐƌŝŶĐĂŶŵĞĚŝĂƚĞDDW ? ?(also known as MT1-MMP) exocytosis 
[31], leading to localised FN degradation, which is required for ɲ ?ɴ ?-dependent FN internalisation 
[32].  
Collagen can be degraded by several proteases, and evidence indicates that MMP14 is the main 
protease involved in collagen endocytosis [30, 33, 34]. In fibroblasts, binding of collagen promotes 
MMP14 expression, associated with increased collagen degradation and phagocytosis [33]. 
Moreover, the serine protease Fibroblast Activation Protein (FAP) is responsible for further cleavage 
of collagen fragments and its activity is required for collagen internalisation [35]. Intriguingly, not 
only MMP activity can control ECM endocytosis, but also mediators of ECM internalisation have 
been shown to impinge on MMP activity. Indeed, downregulation of the collagen receptor Endo180 
leads to increased membrane targeting and activation of MMP14 [36], supporting the idea of a 
complex crosstalk between ECM proteolytic degradation and endocytosis. In contrast, MMP activity 
is not required for Endo180-dependent soluble collagen uptake by lung fibroblasts [37], highlighting 
that more in-depth analysis of the relationship between matrix organisation and endocytosis is 
needed.  
The role of ECM endocytosis in disease 
The balance between ECM deposition and remodelling is crucial for the maintenance of healthy 
tissue homeostasis. Indeed, several pathological conditions, including fibrosis and cancer, are 
characterised by aberrant ECM remodelling [2]. In the heart, excess production and deposition of 
ECM by cardiac fibroblasts results in myocardial stiffness, diastolic and systolic dysfunction [38]. 
During liver fibrosis, increased activation of fibroblasts and hepatic stellate cells drives both collagen 
synthesis and degradation, ultimately resulting in net collagen deposition. This represents the major 
factor causing liver dysfunction. Interestingly, the Endo180-mediated collagen internalisation has 
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been identified as an important protection mechanism in liver fibrosis in vivo, confirming the 
importance of this degradation pathway in preventing excessive collagen deposition [39]. Similarly, 
several pieces of evidence link changes in ECM composition and stiffness to cancer initiation and 
progression [40], suggesting that regulators of ECM remodelling, including ECM endocytosis, could 
be involved in cancer. 
ECM internalisation and cancer 
An intact ECM network provides tissue constraint, therefore limiting tumour growth and migration. 
To overcome this, ECM degradation by MMP release often accompanies cancer progression and 
promotes metastasis formation. Interestingly, not only MMP-dependent, but also endocytosis-
mediated ECM degradation has been shown to impact on cancer invasion and migration. In 
melanoma cell lines, collagen IV is internalised and delivered to lysosomes, where cathepsin K, a 
lysosomal cysteine protease, mediates collagen degradation. This process is required for cell 
invasion [41], suggesting that cathepsin K-mediated intracellular collagen degradation might be 
required for cancer invasion and metastasis (figure 3A).  
While in normal mammary glands Endo180 is only expressed by fibroblasts, this collagen receptor is 
upregulated in a subset of basal-like breast cancers. Similarly to what is observed in fibroblasts, in 
cancer cells Endo180 also mediates clathrin-dependent collagen endocytosis and lysosomal 
degradation [11]. Moreover, overexpression of Endo180, but not an endocytosis-deficient mutant, in 
MCF7 breast cancer cells promotes tumour growth in mouse xenograft experiments, highlighting the 
contribution of ECM internalisation to cancer formation in vivo [42] (figure 3B). Consistently, 
Endo180 levels are increased in metastatic breast cancer patients compared to patients bearing 
localised (non-invasive) breast cancer [43], suggesting that ECM internalisation might be an 
important player in the metastatic cascade. 
Pancreatic cancer is associated with a very reactive stroma, whereby pancreatic stellate cells (PSC) 
secrete high amount of collagen. This contributes to cancer cell growth and metastasis. Both 
pancreatic cancer cells and PSC are able to internalise collagen. Interestingly, the stimulation of 
epithelial-to-ŵĞƐĞŶĐŚǇŵĂů ƚƌĂŶƐŝƚŝŽŶ  ?Dd ? ďǇ ƚƌĂŶƐĨŽƌŵŝŶŐ ŐƌŽǁƚŚ ĨĂĐƚŽƌ ɴ  ?d'&ɴ ? ƐƚƌŽŶŐůǇ
stimulates collagen endocytosis by cancer cells, via upregulation of Endo180 [44] (figure 3C). 
^ŝŵŝůĂƌůǇ ?d'&ɴƉƌŽŵŽƚĞƐ ?ĂƚůĞĂƐƚƉĂƌƚŝĂůůǇ ?ŶĚŽ ? ? ?ĞǆƉƌĞƐƐŝŽŶŝŶŐůŝŽďůĂƐƚŽŵĂĐĞůůůŝŶĞƐ ?ƌĞƐƵůƚŝŶŐŝŶ
increased collagen internalisation and sustained invasion through fibrillar matrices [45]. 
In ovarian cancer cells, the expression of the small GTPase Rab25 has been associated with increased 
migration and invasion [46]. Mechanistically, Rab25 drives the internalisation of FN and its delivery 
to late endosomes and lysosomes. This pathway, which requires ɲ ?ɴ ? integrin and its interactor 
tensin, is required for invasive cell migration and for the activation of mammalian target of 
Rapamycin (mTOR), a key regulator of nutrient signalling [47], suggesting a link between ECM 
internalisation and cancer cell metabolism (figure 3D). Consistent with this, it has been hypothesised 
that collagen-rich ECM might represent a proline-reservoir: upon collagen cleavage by MMPs, its 
degradation sustains proline metabolism in pancreatic tumours [48]. Therefore, the ECM could be 
considered as a source of nutrients to sustain cancer growth.  
Exosome secretion has a key role in controlling cell-cell communication, as well as cancer invasion 
and metastasis. Several ECM components have been identified as exosome cargos and FN is required 
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for the exosome-dependent migratory phenotype in fibrosarcoma cells (figure 3E) [49]. Interestingly, 
a positive feedback loop has been identified in breast cancer cells between invadopodia formation 
and exosome secretion, which sustains cancer cell invasion [50]. Although the exosome cargos 
responsible for this have not been described, one intriguing hypothesis is that ECM degradation at 
invadopodia leads to the generation of ECM fragments, available to be internalised, delivered to 
exosomes and secreted, to locally promote invasiveness. 
Concluding remarks 
ECM internalisation is an important mechanism through which ECM remodelling is controlled. It is 
now clear that the ECM is not a passive by-stander but is actively involved in maintaining tissue 
homeostasis. In pathological conditions, such as in cancer, the complex interplay between cells and 
the ECM provides the right environment to foster cancer growth and migration. It is therefore 
extremely important to deepen our understanding on how ECM endocytosis is regulated, with the 
ultimate aim of developing novel therapeutic strategies based on this process. For this to happen, it 
is essential that the findings obtained from cell lines in 2 dimensional (2D) settings are implemented 
using more physiological 3D environments, such as the use of cell-derived matrices [51] and 3D 
culture systems. It will also be important to assess how matrix composition and 3D organisation 
affect its ability to be endocytosed. Moreover, endocytosis is intimately linked with modulation of 
receptor signalling. Similarly to what observed with receptor tyrosine kinases, it can be expected 
that, upon ECM binding and internalisation, different signalling complexes could be assembled at the 
plasma membrane and along the endocytic pathway. Indeed, recent evidence indicates that 
integrins can signal from endosomes and this is important for anchorage-independent cancer cell 
proliferation [52]. Therefore, it will be important to investigate how ECM endocytosis contributes to 
and cooperates with oncogenic signalling during cancer progression. 
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Figure legends 
Figure 1: schematic representation of ECM organisation. The basement membrane is mainly 
composed of collagen IV, laminins, perlecan, agrin and nidogen; while the interstitial matrix contains 
collagen I, fibronectin, tenascin C and elastin. Adapted from [2]. 
Figure 2. Schematic representation of the endocytic pathways involved in ECM internalisation. 
Collagen can be internalised though an ɲ ?ɴ ? ŝŶƚĞŐƌŝŶ-dependent phagocytic process (A) or via 
Endo180- and clathrin-dependent endocytosis (B ? ? &ŝďƌŽŶĞĐƚŝŶ ŝŶƚĞƌŶĂůŝƐĂƚŝŽŶ ŽĐĐƵƌƐ ǀŝĂ Ă ɲ ?ɴ ?-,
caveolin- or ESCRT-dependent pathway (C); while two laminin (LN) receptors, dystroglycan (DG) and 
ɲ ?ɴ ? ŝŶƚĞŐƌŝŶŵĞĚŝĂƚĞ>E ŝŶƚĞƌŶĂůŝƐĂƚŝŽŶ  ?D). These pathways can lead to the delivery of the ECM 
components to early endosomes (EEs) and lysosomes (Lys), where the ECM is degraded. 
Alternatively, internalised ECM can be re-secreted via Lys fusion or multivesicular body (MVB)-
dependent release of intraluminal vesicles (ILVs). 
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Figure 3. Schematic representation of the contribution of ECM uptake to cancer phenotypes. 
Cathepsin K (catK)-mediated collagen degradation in the lysosomes (Lys) promotes melanoma cell 
invasion (A). Endo180-dependent collagen internalisation mediates breast cancer growth in mouse 
xenograft experiments (B). In pancreatic cancer cells, collagen internalisation is upregulated during 
epithelial to mesenchymal transition (EMT), via increased Endo180 expression induced by 
ƚƌĂŶƐĨŽƌŵŝŶŐŐƌŽǁƚŚ ĨĂĐƚŽƌɴ  ?d'&ɴ ? (C) ?ɲ ?ɴ ? ŝŶƚĞŐƌŝŶĐŽŶƚƌŽůƐ ĨŝďƌŽŶĞĐƚŝŶĞŶĚŽĐǇƚŽƐŝƐ ŝŶŽǀĂƌŝĂŶ
cancer cells, mediating invasive cell migration and mTOR signalling (D). The secretion of ECM-
containing exosomes controls cancer cell migration and invasion (E). 
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